Literature DB >> 9422479

Successful treatment of progressive multifocal leukoencephalopathy with low-dose interleukin-2.

D Przepiorka1, K A Jaeckle, R R Birdwell, G N Fuller, A J Kumar, Y O Huh, I McCutcheon.   

Abstract

A patient with low-grade lymphoma presented 8 months after autologous marrow transplantation with dizziness, aphasia and hemiparesis. Magnetic resonance imaging (MRI) showed an abnormal T2 signal in the frontoparietal region unilaterally. Biopsy of the area demonstrated progressive multifocal leukoencephalopathy positive for JC virus and p53. Treatment with interleukin-2 at 0.5 MU/m2/day i.v. continuous infusion resulted in near complete resolution of symptoms and MRI abnormalities. The absolute number of CD3+CD4+ and CD3-CD56+ cells in the peripheral blood also increased, and the CD4/CD8 ratio normalized. She remains free of evidence of progressive multifocal leukoencephalopathy 1 year off therapy.

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9422479     DOI： 10.1038/sj.bmt.1701010

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


  19 in total

Review 1.  Progressive multifocal leukoencephalopathy: clinical and molecular aspects.

Authors:  Eleonora Tavazzi; Martyn K White; Kamel Khalili
Journal:  Rev Med Virol       Date:  2011-09-21       Impact factor: 6.989

2.  Case files of the New York City poison control center: paradichlorobenzene-induced leukoencephalopathy.

Authors:  Stephanie H Hernandez; Sage W Wiener; Silas W Smith
Journal:  J Med Toxicol       Date:  2010-06

3.  Progressive multifocal leukoencephalopathy in a patient with multiple myeloma.

Authors:  Masaru Akiyama; Toru Takahashi; Sinjo Nomura; Yoshimi Yamashita; Katsuhiro Hatao
Journal:  Int J Hematol       Date:  2010-05-28       Impact factor: 2.490

4.  Progressive multifocal leukoencephalopathy in transplant recipients.

Authors:  Farrah J Mateen; RajaNandini Muralidharan; Marco Carone; Diederik van de Beek; Daniel M Harrison; Allen J Aksamit; Mary S Gould; David B Clifford; Avindra Nath
Journal:  Ann Neurol       Date:  2011-08       Impact factor: 10.422

5.  Interleukin-15 superagonist (N-803) treatment of PML and JCV in a post-allogeneic hematopoietic stem cell transplant patient.

Authors:  Aabha Oza; Michael P Rettig; Phil Powell; Kathryn O'Brien; David B Clifford; Julie Ritchey; Leah Gehrs; Julia Hollaway; Eugene Major; Todd A Fehniger; Christopher A Miller; Patrick Soon-Shiong; Amy Rock; John F DiPersio
Journal:  Blood Adv       Date:  2020-06-09

Review 6.  AIDS-associated progressive multifocal leukoencephalopathy : current management strategies.

Authors:  Mark T M Roberts
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 7.  Progressive multifocal leukoencephalopathy and natalizumab.

Authors:  Kerstin Hellwig; Ralf Gold
Journal:  J Neurol       Date:  2011-06-07       Impact factor: 4.849

Review 8.  Natalizumab and progressive multifocal leucoencephalopathy.

Authors:  J R Berger
Journal:  Ann Rheum Dis       Date:  2006-11       Impact factor: 19.103

Review 9.  Progressive multifocal leukoencephalopathy in HIV-1 infection.

Authors:  Paola Cinque; Igor J Koralnik; Simonetta Gerevini; Jose M Miro; Richard W Price
Journal:  Lancet Infect Dis       Date:  2009-10       Impact factor: 25.071

Review 10.  Use of interleukin-2 for management of natalizumab-associated progressive multifocal leukoencephalopathy: case report and review of literature.

Authors:  Divyanshu Dubey; Yinan Zhang; Donna Graves; Allen D DeSena; Elliot Frohman; Benjamin Greenberg
Journal:  Ther Adv Neurol Disord       Date:  2015-12-17       Impact factor: 6.570
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.